Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2004-4-2
pubmed:abstractText
The primary objective was to examine the economic burden associated with acute myeloid leukemia (AML), a deadly hematological malignancy. AML is the most common form of acute leukemia in adults, particularly in individuals over 60 years of age; AML also accounts for 15-20% of childhood leukemia.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0305-7372
pubmed:author
pubmed:issnType
Print
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
237-47
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:15059647-Adolescent, pubmed-meshheading:15059647-Adult, pubmed-meshheading:15059647-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15059647-Bone Marrow Transplantation, pubmed-meshheading:15059647-Child, pubmed-meshheading:15059647-Child, Preschool, pubmed-meshheading:15059647-Combined Modality Therapy, pubmed-meshheading:15059647-Cost Savings, pubmed-meshheading:15059647-Cost of Illness, pubmed-meshheading:15059647-Cost-Benefit Analysis, pubmed-meshheading:15059647-Female, pubmed-meshheading:15059647-Health Care Costs, pubmed-meshheading:15059647-Hospitalization, pubmed-meshheading:15059647-Humans, pubmed-meshheading:15059647-Length of Stay, pubmed-meshheading:15059647-Leukemia, Myeloid, Acute, pubmed-meshheading:15059647-Male, pubmed-meshheading:15059647-Recurrence, pubmed-meshheading:15059647-Severity of Illness Index, pubmed-meshheading:15059647-United States
pubmed:year
2004
pubmed:articleTitle
Economic burden of acute myeloid leukemia: a literature review.
pubmed:affiliation
Global Outcomes Research-Oncology, Pharmacia Corporation, Via Robert Koch 1.2, 20152 Milan, Italy. alberto.redaelli@pharmacia.com
pubmed:publicationType
Journal Article, Comparative Study, Review, Legislation